Kashiv and JAMP Launch PEXEGRA and FILRA Biosimilars in Canada
September 24, 2025
Kashiv BioSciences, announced the commercial launch of PEXEGRA, a biosimilar referencing Neulasta, and FILRA, a biosimilar referencing Neupogen, in the Canadian market. Both biosimilars will